Japan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Japan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 0.5% year on year. In 2019, the country was number 152 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 83 Cases. India lead the ranking with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.

Loading...

Date Units (Cases)
2019 83.00
2018 83.00
2017 86.00
2016 79.00
2015 78.00
Download all data from 2007 to 2019

How does Japan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
150 #150
Botswana
84 2019 -1.2 % +15.4 % View data
152 #152
Japan
83 2019 +0.0 % +0.5 % View data
153 #153
Venezuela
80 2019 +5.3 % +25.2 % View data
Compare all 359 countries

Go Top